Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects

What is the purpose of this trial?

The aim of the study is to provide insight into the impact of the immunosuppressant drug sirolimus, on the antidepressant effects of the prototypal rapid-acting antidepressant medication, ketamine.


Participation Guidelines

Ages: 21 - 65 years

Gender: Both


Pfeiffer Research Foundation

Start Date: 06/01/2016

End Date: 12/31/2016

Last Updated: 04/05/2019

Study HIC#: 1504015604

Get Involved

For more information about this study, contact:
Selin O. Goktas
+1 203-932-5711
selin.goktas@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image